The University of Chicago Header Logo

Connection

Kapuluru Reddy to End Stage Liver Disease

Back to Details
This is a "connection" page, showing publications Kapuluru Reddy has written about End Stage Liver Disease.
Kapuluru Reddy
Connection Strength
0.066
End Stage Liver Disease
  1. Rifaximin Decreases the Incidence and Severity of Acute Kidney Injury and Hepatorenal Syndrome in Cirrhosis. Dig Dis Sci. 2016 12; 61(12):3621-3626.
    View in: PubMed
    Score: 0.066
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.